Arbutus Biopharma (ABUS) Accumulated Expenses (2014 - 2019)
Arbutus Biopharma (ABUS) posted Accumulated Expenses of $137000.0 for Q4 2019, down 32.51% sequentially from $203000.0 in Q3 2019, and down 89.71% YoY from $1.3 million in Q4 2018.
Arbutus Biopharma (ABUS) Accumulated Expenses (2014 - 2019) Analysis & Trends
Arbutus Biopharma has reported Accumulated Expenses for 4 years, with the latest figure at $137000.0 in Q4 2019.
- Quarterly Accumulated Expenses fell 89.71% year-over-year to $137000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $137000.0 (down 89.71% YoY) and the FY2019 annual result came in at $137000.0, down 89.71% from the prior year.
- Accumulated Expenses eased to $137000.0 in Q4 2019 per ABUS's latest filing, from $203000.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $1.3 million in Q4 2018 and troughed at $28000.0 in Q1 2015.
- A 3-year average of $558250.0 and a median of $416500.0 in 2015 frame the typical range for Accumulated Expenses.
- The widest YoY moves for Accumulated Expenses: up 89.71% in 2019, down 89.71% in 2019.
- Over 3 years, Accumulated Expenses stood at $952000.0 in 2015, then surged by 39.81% to $1.3 million in 2018, then tumbled by 89.71% to $137000.0 in 2019.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $137000.0, $203000.0, and $342000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 137,000.00 |
| Sep 30, 2019 | 203,000.00 |
| Jun 30, 2019 | 342,000.00 |
| Mar 31, 2019 | 982,000.00 |
| Dec 31, 2018 | 1.33 Mn |
| Sep 30, 2015 | 952,000.00 |
| Jun 30, 2015 | 491,000.00 |
| Mar 31, 2015 | 28,000.00 |
| Dec 31, 2014 | 2.87 Mn |